Overview

An Observational Study of Ertapenem in Outpatient Parenteral Antibiotic Therapy (OPAT) for Complicated Urinary Tract Infections.

Status:
Unknown status

Trial end date:
2014-09-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to determine the outcomes when using ertapenem for complicated urinary tract infections in the OPAt setting. The study hypothesis: Ertapenem is an efficacious and safe therapeutic option for complicated urinary tract infections in the OPAt setting.

Details

Lead Sponsor:

National University Hospital, Singapore

Collaborator:

Merck Sharp & Dohme Corp.

Treatments:

Anti-Bacterial Agents
Ertapenem